A large review of existing research looked at whether taking aspirin helps patients with colorectal cancer after they finish their standard treatments. The study specifically looked at two main goals: how long patients lived without the disease returning and their overall survival rates.
Researchers found that aspirin did not show a significant benefit for either of these goals. The results were neutral, meaning that patients who took aspirin did not live longer or stay cancer-free longer than those who did not. This finding is based on a mix of different studies, which included some with inconsistent data.
Because the data across these studies was varied and safety information was limited, the results are not definitive. Currently, there is no strong evidence to suggest that aspirin works as a secondary prevention tool for colorectal cancer. Patients should talk to their doctors about the best ways to manage their health after treatment.
Common questions
Does aspirin help people live longer after colorectal cancer treatment?
The analysis found no statistically significant improvement in overall survival for patients who took aspirin after their standard treatment. The results were neutral, meaning aspirin did not show a clear benefit in extending life for those who had already completed their primary cancer therapy.
Can aspirin prevent colorectal cancer from coming back?
The study looked at disease-free survival and found no significant improvement for patients taking aspirin. Because the data was inconsistent across different studies, there is currently no evidence that aspirin works as a secondary prevention tool for colorectal cancer.
Is it safe to take aspirin after cancer treatment?
Safety data for aspirin in this specific group was limited and variably reported across the studies. Because of these inconsistencies and the lack of clear benefits, you should consult your doctor before starting any new supplement or medication after your treatment.
